-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Immunocore Holdings plc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2023 to 2024.
- Immunocore Holdings plc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending March 31, 2024 was -$24.1 M, a 25.7% decline year-over-year.
- Immunocore Holdings plc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$60.9 M, a 48.9% decline from 2022.
- Immunocore Holdings plc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$40.9 M, a 77.3% increase from 2021.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)